Epstein Secrets

roff Subject: Fwd: FOURIER: Significant LDL Reduction with Evolocumab Date: Fri, 24 Mar 2017 11:17:36 +0000 Lesley please forward to Jeffrey rs Rony Shimony, M.D. F.A.C.C. Associate Professor of Medicine, Cardiology Icahn School of Medicine at Mount Sinai Director, Clinical Cardiology Mount Sinai West

otic disease should discuss their LDL cholesterol with their physician and consider whether they need to lower it further." Reference Sabatine MS. Giugliano RP, Keech AC, et al. N Engl J Med. 2017;doi:NEJMoa1615664 http://www.nejm.orq/doUpdf/10.1056/NEJMoa 1615664 Sabatine M. Primary Results of the Further

FOURIER: Significant LDL Reduction with Evolocumab Date: March 24, 2017 at 7:17:36 AM EDT To: Lesley Groff < Lesley please forward to Jeffrey rs Rony Shimony, M.D. F.A.C.C. Associate Professor of Medicine, Cardiology Icahn School of Medicine at Mount Sinai Director, Clinical Cardiology Mount Sinai West

otic disease should discuss their LDL cholesterol with their physician and consider whether they need to lower it further." Reference Sabatine MS, Giugliano RP, Keech AC, et al. N Eng! J Med. 2017;doi:NEJMoa1615664 http://www.nejm.orgidoi/pdf/10.1056/NEJMoa1615664 Sabatine M. Primary Results of the Further

duction with Evolocumab Date: Fri, 24 Mar 2017 11:18:21 +0000 will do..thanks! On Mar 24, 2017, at 7:17 AM, Lesley please forward to Jeffrey rs Rony Shimony, M.D. F.A.C.C. Associate Professor of Medicine, Cardiology Icahn School of Medicine at Mount Sinai Director, Clinical Cardiology Mount Sinai West

otic disease should discuss their LDL cholesterol with their physician and consider whether they need to lower it further." Reference Sabatine MS, Giugliano RP, Keech AC, et al. N Eng! J Med. 2017;doi:NEJMoa1615664 http://www.ne m.orgidoi/pdftl0.1056/NEJMoa1615664 Sabatine M. Primary Results of the Further